Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Microbial Immunology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1655244

Photodynamic Inactivation of Staphylococcus aureus with Rose Bengal Reduces Superantigen Activity

Provisionally accepted
  • 1Laboratory of Photobiology and Molecular Diagnostics, Intercollegiate Faculty of Biotechnology of University of Gdańsk and Medical University of Gdańsk, Gdańsk, Poland
  • 2University of Gdańsk, Gdańsk, Poland
  • 3Laboratory of Experimental and Translational Immunology, Intercollegiate Faculty of Biotechnology of University of Gdańsk and Medical University of Gdańsk, Gdańsk, Poland
  • 4Department of Pathomorphology, University Hospital, Kraków, Poland
  • 5Uniwersytet Gdanski, Gdańsk, Poland

The final, formatted version of the article will be published soon.

Atopic dermatitis (AD) is a chronic inflammatory skin disorder marked by barrier dysfunction and immune dysregulation. Colonization of lesional skin by Staphylococcus aureus, present in up to 80–100% of cases, exacerbates inflammation, in part through production of superantigenic toxins. While standard treatments such as topical corticosteroids, antibiotics, and antiseptic baths are widely used, their outcomes remain variable and often inadequate, highlighting the need for alternative strategies that minimize adverse effects and resistance development. In this study, we evaluated antimicrobial photodynamic inactivation (aPDI) using rose bengal (RB), a photosensitizer activated by visible light, as a potential approach to reduce S. aureus colonization and virulence. Across in vitro, ex vivo, and murine in vivo models, RB-mediated aPDI significantly decreased S. aureus viability and markedly attenuated the expression and activity of staphylococcal enterotoxins. Transcript and protein analyses confirmed substantial reductions in superantigenic activity post-aPDI. These effects were dependent on the combination of both RB and light, with no significant impact observed with either component alone. Our findings indicate that RB-based aPDI may represent a promising non-antibiotic approach to limit S. aureus viability and toxin activity in the context of AD. Our data contribute to the understanding of how photodynamic inactivation affects S. aureus virulence and highlight a model for studying the impact of microbial factors on skin immune responses in AD.

Keywords: BACTERIAL ENTEROTOXINS, MRSA, Antimicrobial photodynamic therapy, bacterialcolonization, atopic dermatitis, Rose Bengal

Received: 27 Jun 2025; Accepted: 17 Sep 2025.

Copyright: © 2025 Ogonowska, Kobiela, Hulacka, Gutowska-Owsiak and Nakonieczna. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Joanna Nakonieczna, joanna.nakonieczna@biotech.ug.edu.pl

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.